Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,398.00
Bid: 12,398.00
Ask: 12,400.00
Change: 66.00 (0.54%)
Spread: 2.00 (0.016%)
Open: 12,350.00
High: 12,414.00
Low: 12,314.00
Prev. Close: 12,332.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-UK-made AstraZeneca vaccines quietly sent to Australia -Sydney Morning Herald

Thu, 08th Apr 2021 06:53

(Adds Australian PM spokesman, UK health secretary comments)

LONDON, April 8 (Reuters) - Hundreds of thousands of doses
of the AstraZeneca vaccine have been flown to Australia
from Britain but the source of the shipments was kept quiet to
avoid any controversy in Britain, The Sydney Morning Herald
reported.

As countries race to vaccinate their populations against the
coronavirus, the export of immunisations has come into dispute
wherever large numbers of people are awaiting a shot. The
European Union, hit by delays in vaccine supply, introduced
export controls on EU-produced shots in January.

The Sydney Morning Herald said that more than 700,000
vaccines flown to Australia were manufactured in Britain and not
in Europe as had been widely believed. The shipments arrived
after the EU introduced the curbs on vaccine exports, it said.

British Health Secretary Matt Hancock said his government
had not sent any vaccines to Australia and any exports that had
taken place were a matter for the companies concerned.

"In terms of what the companies do, these companies are
manufacturing for all around the world," Hancock told Sky News.

"What matters for us as the UK government is making sure
that we get the supplies that we have contracted from the
companies."

A spokesman for Australian Prime Minister Scott Morrison
declined to comment.

The newspaper cited an unidentified British official as
saying that the shipments to Australia were never at the expense
of the UK’s vaccine rollout - one of the swiftest in the world.

In March, the European Commission blocked the shipment of
250,000 doses of the AstraZeneca vaccine to Australia, and
Morrison has blamed the EU for delays to his country's
vaccination programme.

Britain has given 31.7 million people a first dose of a
COVID-19 vaccine. The number of infections, hospitalisations and
deaths have all fallen in recent weeks.

Israel is the world leader in vaccinating its population
against COVID-19, followed by the United Arab Emirates, Chile,
Britain, the United States, Bahrain, Serbia and Hungary,
according to Our World in Data.
(Reporting by Guy Faulconbridge; additional reporting by Colin
Packham and Sarah Young; Editing by Mark Heinrich)

More News
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 08:04

C4X receives USD11 million from AstraZeneca following NRF2 trials

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
2 Jan 2024 17:05

British equities slip on higher yields, financials drag

FTSE 100 down 0.2%, FTSE 250 off 0.9%

*

Read more
2 Jan 2024 12:01

LONDON MARKET MIDDAY: London stocks make largely soft start to 2024

(Alliance News) - Stock prices in London were mostly lower at midday on Tuesday in a slow start to the new year, reacting to the UK manufacturing sector finishing a tricky 2023 with a further contraction in December.

Read more
2 Jan 2024 11:00

Weight-loss drugs: Who, and what, are they good for?

Jan 2 (Reuters) - Powerful weight-loss medicines like Novo Nordisk's Wegovy leapt into public view in 2023, from social media to doctors' offices and cocktail parties, offering a new way to address record obesity rates.

Read more
2 Jan 2024 11:00

What other health conditions might weight-loss drugs treat?

Jan 2 (Reuters) - Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways.

Read more
2 Jan 2024 08:48

LONDON MARKET OPEN: New Year begins largely green amid slew of PMIs

(Alliance News) - Stock prices in London opened mostly up on Tuesday, the first day of trading in 2024, reacting to slightly improved factory activity in China, with more manufacturing PMIs from major economies due.

Read more
2 Jan 2024 08:26

AstraZeneca and Sanofi received approval in China for RSV antibody

(Alliance News) - AstraZeneca PLC and Sanofi SA's long-acting monoclonal antibody Beyfortus received approval for use in China to prevent respiratory syncytial virus disease, Astra said on Tuesday.

Read more
2 Jan 2024 07:57

LONDON BRIEFING: AstraZeneca, Sanofi's RSV treatment approved in China

(Alliance News) - Stock prices in London are expected to open higher on Tuesday, reacting to a slight expansion in manufacturing activity in China and ahead of a slew of manufacturing PMI data including for the UK.

Read more
27 Dec 2023 17:04

Rate-cut optimism, autos push UK stocks higher

FTSE 100 up 0.4%, FTSE 250 adds 0.5%

*

Read more
27 Dec 2023 17:02

LONDON MARKET CLOSE: Stocks start week higher as 2024 draws to close

(Alliance News) - Equities in London kicked off an abbreviated trading week with gains on Wednesday, on continued US interest rate optimism at the end of 2024.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.